18 Mar 2024 --- Dermavant Sciences unveils phase 3 trial data on atopic dermatitis treatment in patients with skin of color with VTAMA (Tapinarof) cream 1%. The immuno-dermatology-focused biopharmaceutical company demonstrates the statistically significant efficacy of the VTAMA cream in treating atopic dermatitis in adults and children as young as two years old.
